Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Ultrasound Doppler, Vaccination site pain
Clinical narrative: T100.5; minor myalgias; sl headache (L) temporal; very sl sore throat; Mild injection site pain; This is a spontaneous report received from contactable reporter(s) (Physician and Other HCP). The reporter is the patient.  A 68 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid left, administration date 11Oct2021 09:30 (Lot number: FE3590) at the age of 68 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Acute (L) iliac artery and (L) popliteal artery occlusion" (unspecified if ongoing), notes: other_medical_history: Acute (L) iliac artery and (L) popliteal artery occlusion; "Covid-19" (unspecified if ongoing), notes: if covid prior vaccination: Yes; "Acute (L) iliac artery and (L) popliteal artery occlusion" (unspecified if ongoing), notes: other_medical_history: Acute (L) iliac artery and (L) popliteal artery occlusion; "Arterial blood Clotting", start date: 04Oct2021 (ongoing); "Embolectomy", start date: 04Oct2021 (unspecified if ongoing), notes: Hospitalised stay for2days. required visit toEmergency Room,Intensive Care Unit,outcome:RecoveringDid the event required the initiation of new medication was Yes (Embolectomy Eliquis). Concomitant medication(s) included: FLUAD QUAD, administration date 25Sep2021; ELIQUIS taken for thrombosis, start date: 05Oct2021 (ongoing); IBUPROFEN; DIPHENHYDRAMINE; TESTOSTERONE CYPIONATE. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EK9231, Location of injection: Left Deltoid, Vaccine Administration Time: 06:00 PM, Route of Administration: Intramuscular), administration date: 28Dec2020, when the patient was 67 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EL8982, Location of injection: Left Deltoid, Vaccine Administration Time: 06:00 PM, Route of Administration: Intramuscular), administration date: 18Jan2021, when the patient was 67 years old, for Covid-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 11Oct2021 15:30, outcome "not recovered", described as "T100.5"; MYALGIA (non-serious) with onset 11Oct2021 15:30, outcome "not recovered", described as "minor myalgias"; HEADACHE (non-serious) with onset 11Oct2021 15:30, outcome "not recovered", described as "sl headache (L) temporal"; OROPHARYNGEAL PAIN (non-serious) with onset 11Oct2021 15:30, outcome "not recovered", described as "very sl sore throat"; VACCINATION SITE PAIN (non-serious) with onset 11Oct2021 15:30, outcome "not recovered", described as "Mild injection site pain". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, myalgia, headache, oropharyngeal pain, vaccination site pain.  Additional Information:6-8 hr post-injection, T100.5, minor myalgias, sl headache (L) temporal, very sl sore throat. Mild injection site pain. Persistent 12 hr post-inhec.Prior to vaccination, was the patient diagnosed with COVID-19 was yes.Since the vaccination, has the patient been tested for COVID-19 was Yes. Facility where the most recent COVID-19 vaccine was administered was Pharmacy.Vaccination Facility Type was hospital.Hospitalised stay for2days. required visit toEmergency Room,Intensive Care Unit,outcome:RecoveringDid the event required the initiation of new medication was Yes (Embolectomy Eliquis).  No follow-up attempts are possible. No further information is expected.